Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 Feb;213(2):215-216.
doi: 10.1097/JU.0000000000004308. Epub 2024 Dec 3.

Editorial Comment

Rachel Passarelli  1 , Benjamin Lichtbroun  1 , Saum Ghodoussipour  1 , Vignesh T Packiam  1
Affiliations
Comment

Editorial Comment

Rachel Passarelli et al. J Urol. 2025 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Prasad S, Shishkov D, Mihaylov MV et al. Primary Chemoablation of Recurrent Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer with UGN-102: A Single-arm, Open-label, Phase 3 Trial (ENVISION). J Urol. 2024 - PubMed
    1. Prasad SM, Huang WC, Shore ND, et al. Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 +/− Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS). J Urol. Oct 2023;210(4):619–629. doi:10.1097/JU.0000000000003645 - DOI - PubMed
    1. Tan WS, McElree IM, Davaro F, et al. Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guerin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. Oct 2023;6(5):531–534. doi:10.1016/j.euo.2023.06.011 - DOI - PubMed

LinkOut - more resources